[The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA]
- PMID: 1318558
[The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA]
Abstract
Thirty-five patients with hepatic hemangioma (n = 12), metastasis (n = 10), hepatocellular carcinoma (HCC) (n = 10) and focal nodular hyperplasia (n = 3) were examined with the fast low-angle shot (FLASH) technique and an intravenous bolus injection of Gd-DTPA. In order to differentiate the lesions, the following criteria were used: a) pre Gd-DTPA intensity of lesions; b) post Gd-DTPA patterns of contrast enhancement. On the basis of these criteria, an unquestionable differential diagnosis could be made. Hemangiomas were characterized by an hypointense mass before Gd-DTPA, by peripheral contrast enhancement and by subsequent continuous hyperintense fill-in; thus, hemangiomas were visualized as hyperintense lesion during the late phase. Before contrast administration hypovascular metastases appeared as hypointense; they were characterized by delayed uptake of contrast agent. HCCs were hyperintense lesions before contrast administrations; then, quick contrast enhancement and rapid decrease in signal intensity were observed with visualization of a hyperintense ring due to the capsule. Finally, focal nodular hyperplasia appeared isointense or hypointense relative to normal liver on precontrast scans; the lesions were enhanced transiently with subsequent quick dismission of contrast agent. This initial experience suggests dynamic contrast-enhanced MR imaging as an effective method to improve the differential diagnosis among hepatic tumors when precontrast T2-weighted images are equivocal.
Similar articles
-
Small hepatocellular carcinoma and cavernous hemangioma: differentiation with dynamic FLASH MR imaging with Gd-DTPA.Radiology. 1989 May;171(2):339-42. doi: 10.1148/radiology.171.2.2539606. Radiology. 1989. PMID: 2539606
-
MR imaging of focal nodular hyperplasia of the liver: value of contrast-enhanced dynamic study.Radiat Med. 1997 Jan-Feb;15(1):29-35. Radiat Med. 1997. PMID: 9134582
-
Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.Radiology. 1996 Jul;200(1):59-67. doi: 10.1148/radiology.200.1.8657946. Radiology. 1996. PMID: 8657946 Clinical Trial.
-
Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).Magn Reson Imaging Clin N Am. 1996 Feb;4(1):61-72. Magn Reson Imaging Clin N Am. 1996. PMID: 8673717 Review.
-
Liver I: Currently available gadolinium chelates.Magn Reson Imaging Clin N Am. 1996 Feb;4(1):37-51. Magn Reson Imaging Clin N Am. 1996. PMID: 8673715 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical